傑的地盤

多虧基亞的解盲失敗，我的美時空單才有幸回補，

現在公司派及媒體不斷的放送併購以及未來營收認列的利多消息，

可見主力還沒跑掉，散戶還在加碼續抱當中，這檔未來值得追蹤，看看Lotus能端出什麼菜來。

延伸閱讀
http://koreajoongangdaily.joins.com/news/article/article.aspx?aid=2986713
內文中提到Dream Pharma 2012年的營收腰斬、去年虧損、還有賄賂醜聞等

Dream Pharma hasn’t been a big help, and has even tarnished the group’s image. The company, which was founded in 1995 as Hanwha Corporation’s pharmaceutical unit, had sales of more than 170 billion won in 2009, but after a tax investigation and a corruption scandal regarding rebates on medicine supplies, the company has been deteriorating. In 2012, its sales were cut in half to 85.5 billion won and last year it had net losses.